Indeed, PDE inhibitors are currently being evaluated with the hope of shortening the duration of treatment for tuberculosis (TB) and for the prevention and limitation of both pulmonary pathology and bacterial drug resistance (28). Here, ALDH7A1 is linked to tuberculosis.